Navigation Links
Savient Pharmaceuticals to Present at the Citi 2011 Global Healthcare Conference
Date:2/17/2011

EAST BRUNSWICK, N.J., Feb. 17, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that John H. Johnson, Chief Executive Officer of Savient will present at the Citi 2011 Global Healthcare Conference on Tuesday, March 1, 2011, at 4:00 p.m. Eastern Time.  The conference will be held at the New York Hilton in New York, NY.  

A live webcast of the presentation can be accessed through the investor relations section of the Company's website www.savient.com.  Following the live presentation, a replay of the webcast will be available on the Company's website for 30 days.

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA™ (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S.

SVNT - G


'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
2. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
3. Savient Submits Biologics License Application (BLA) for pegloticase
4. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
6. Savient Announces Appointment of David Gionco as Chief Financial Officer
7. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
8. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
9. Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
10. Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout
11. Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Albany, NewYork (PRWEB) September 01, 2014 ... Pharma, Biotech and Diagnostics report provides comprehensive understanding ... and agreements entered into by the worlds leading ... detailed understand and analysis of how and why ... flexibility of a prospective partner’s negotiated deals terms ...
(Date:8/31/2014)... August 31, 2014 This is ... state of the Epoxy Hardener industry in ... overview of the industry, including definitions, applications and ... domestic market analysis are provided with a focus ... the market. A comparison between the international and ...
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... valued at $5.6 billion in 2019. It is ... from 2013 to 2019, and was valued at ... report published by Transparency Market Research. , For ... visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, ...
(Date:8/29/2014)... 29, 2014 Local veterinarian, Dr. Keith ... are seeking candidates to participate in an investigational study ... The ultimate goal of this study is to determine ... one or two arthritically affected joints can help reduce ... Candidates for the current investigational study must be older ...
Breaking Biology Technology:Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 4Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 2Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 3Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... TALLAHASSEE, Fla., April 13, 2012  The Large Urology ... urologists, today disputed a study published this week ... leaders stressed that the study grossly misrepresents the ... physicians for adopting evidence based clinical protocols. They ...
... 12, 2012 Shire plc (LSE: SHP, NASDAQ: ... quarter 2012 earnings on Thursday April 26, 2012. ... EDT Investor conference call time: 14:00 BST / 09:00 EDT, ... Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer ...
... informatics tools, increases the likelihood that it will be possible ... the brain without having to measure every aspect of it. ... brain in silicothe goal of the proposed Human Brain Projecta ... opens to a world of predictive biology," says Henry Markram, ...
Cached Biology Technology:Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study 2Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study 3Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study 4Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012 2Data mining opens the door to predictive neuroscience 2
(Date:9/1/2014)... ago, electron microscopy revealed the presence of tiny blob-like ... But scientists still don,t know what they do ... believed to be crucial to the life of a ... disease treatment., In the Journal of Cell Biology ... from various backgrounds, from biophysics to cell biology, to ...
(Date:8/31/2014)... discovered that ,good, cholesterol is turned ,bad, by a ... was found to damage ,good, HDL cholesterol, which removes ... , Low levels of HDL, High Density Lipoprotein, are ... MG being common in the elderly and those with ... from the British Heart Foundation (BHF) and published in ...
(Date:8/31/2014)... challenges in modern medicine is developing drugs that are ... and side-effects to the patient. Such properties are directly ... Ideally, the drug should have a shape that is ... binds it with high specificity. Publishing in Nature ... acid that can impact the 3D structure of bioactive ...
Breaking Biology News(10 mins):Scientists call for investigation of mysterious cloud-like collections in cells 2Sugar substance 'kills' good HDL cholesterol, new research finds 2A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3
... almost seven years in secret. Most people did ... characterization department at Sandia National Laboratories was contributing important ... anthracis, the spores that cause the disease anthrax. The ... several news media offices and to two U.S. senators. ...
... HOUSTON, Aug. 21, 2008 Noise can be irritating ... and maybe even 60-foot whales in the Gulf of Mexico. ... that man-made noise may be a cause of stress for ... a five-year study show that noise pollution especially noise ...
... DNA into the space of a typical chromosome, a ... material it contains. "It is like compacting your ... Emeritus in Physics at the University of Chicago. ... showing that these and related organisms may have evolved ...
Cached Biology News:FBI unveils science of anthrax investigation 2FBI unveils science of anthrax investigation 3Unique study shows oil, gas seismic work not affecting Gulf sperm whales 2Unique study shows oil, gas seismic work not affecting Gulf sperm whales 3Exploding chromosomes fuel research about evolution of genetic storage 2Exploding chromosomes fuel research about evolution of genetic storage 3
MMP-20 Immunogen: Activated recombinant human MMP-2 Storage: -20 C, Avoid Freeze/Thaw Cycles...
Rabbit anti-T-box 6...
Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...
...
Biology Products: